InsidersTradesSigma
Follow the Q BioMed Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Q BioMed Inc. has published 2 reports. The latest transaction was reported on 31 May 2022 (Attribution). Among the most active insiders: Corin Denis. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Q BioMed Inc. is a biotechnology company focused on the development and commercialization of pharmaceutical products for serious diseases. It aims to improve patients' quality of life through innovative solutions.